Cargando…
SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer
Resistance is the major cause of treatment failure and disease progression in non-small cell lung cancer (NSCLC). There is evidence that hypoxia is a key microenvironmental stress associated with resistance to cisplatin, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), and...
Autores principales: | Xu, Rui, Luo, Xin, Ye, Xuan, Li, Huan, Liu, Hongyue, Du, Qiong, Zhai, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351465/ https://www.ncbi.nlm.nih.gov/pubmed/34381712 http://dx.doi.org/10.3389/fonc.2021.682762 |
Ejemplares similares
-
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014) -
ATGL-Catalyzed Lipolysis Regulates SIRT1 to Control PGC-1α/PPAR-α Signaling
por: Khan, Salmaan Ahmed, et al.
Publicado: (2015) -
Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway
por: Shi, Yixian, et al.
Publicado: (2016) -
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players
por: Siblini, Youssef, et al.
Publicado: (2022) -
QKI 6 ameliorates CIRI through promoting synthesis of triglyceride in neuron and inhibiting neuronal apoptosis associated with SIRT1‐PPARγ‐PGC‐1α axis
por: Liu, Rui, et al.
Publicado: (2021)